CYTK · Cytokinetics Inc
$77.18
-0.56 (-0.72%)
At close · Aug 20
Market Cap
$10.65B
Shares
139.02M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-13 | — | |
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-08 | 2026-06-30 | |
| 8-K | 2026-05-27 | — | |
| 8-K | 2026-05-08 | 2026-05-06 | |
| 8-K | 2026-05-05 | — | |
| 8-K | 2026-05-05 | — | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| DEF 14A | 2026-04-17 | 2026-05-27 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-02-17 | — | |
| 8-K | 2025-12-19 | — | |
| 8-K | 2025-12-12 | — | |
| 8-K | 2025-11-14 | 2025-11-13 | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-09-22 | 2025-09-16 | |
| 8-K | 2025-09-16 | 2025-09-15 | |
| 8-K/A | 2025-09-08 | 2025-08-31 | |
| 8-K | 2025-09-03 | 2025-08-31 | |
| 8-K | 2025-09-02 | 2025-08-30 | |
| 8-K | 2025-08-20 | 2025-08-19 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-05-16 | 2025-05-14 | |
| 8-K | 2025-05-06 | — | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-01 | 2025-04-29 | |
| DEF 14A | 2025-04-10 | 2025-05-14 | |
| 8-K | 2025-03-10 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-02-11 | 2025-02-10 | |
| 8-K | 2024-12-16 | — | |
| 8-K | 2024-11-19 | 2024-11-18 | |
| 8-K | 2024-11-07 | 2024-11-01 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-08-15 | 2024-08-13 | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-07 | — | |
| 8-K | 2024-06-05 | — | |
| 8-K | 2024-05-28 | — | |
| 8-K | 2024-05-22 | — | |
| 8-K | 2024-05-22 | — |
Showing 1–50 of 226 filings
Key facts
CIK
1061983
CUSIP
23282W605
13F (30d)
443 filings
439 filers
Visit website
Investor relations